Aivlosin (tylvalosin)
Respiratory and enteric diseases in swine and poultry
ApprovedCommercial
Key Facts
Indication
Respiratory and enteric diseases in swine and poultry
Phase
Approved
Status
Commercial
Company
About Vetoquinol
Vetoquinol is an independent, family-founded animal health company with a mission to improve animal health and well-being through innovative pharmaceutical solutions. The company has built a strong international presence, generating over €500 million in annual revenue through a direct commercial footprint in key markets and a network of distributors. Its strategy focuses on therapeutic innovation, geographic expansion, and strategic acquisitions to strengthen its position in the high-growth animal health market, which is driven by trends in pet humanization, food safety, and livestock productivity.
View full company profile